Lamal (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels, which stabilizes neuronal membranes and reduces the release of excitatory neurotransmitters such as glutamate. This action diminishes neuronal hyper‑excitability, helping to prevent seizures and stabilize mood.

The dosage of Lamal is individualized by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and response to therapy. The prescriber determines the starting dose and any subsequent titration.

Safety data for lamotrigine in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks, and discuss options with the patient. Breastfeeding decisions should also consider drug transfer into milk.

To order Lamal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with older antiepileptics such as carbamazepine or phenytoin, lamotrigine offers a broader spectrum covering both focal and generalized seizures and has mood‑stabilizing properties useful in bipolar disorder. Its side‑effect profile differs, with a lower risk of sedation but a notable risk of skin reactions.

Lamal should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Maintaining these conditions helps preserve the tablet’s stability and potency throughout its shelf life.

Lamal is taken orally, usually as a tablet, with or without food. The exact dosing schedule—once or twice daily—depends on the prescriber’s plan and the patient’s therapeutic response.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and the emergence of suicidal thoughts. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to lamotrigine or any component of the formulation should avoid Lamal. Caution is also advised for individuals with severe hepatic impairment, a history of serious skin reactions, or those taking interacting enzyme‑inducing drugs without proper dose adjustment.